Robak P - Search Results

1

An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma.

Mikulski D, Robak P, Mirocha G, Ryżewska W, Stańczak K, Okoński K, Kościelny K, Robak T. Mikulski D, et al. Among authors: robak t, robak p. Contemp Oncol (Pozn). 2023;27(3):139-146. doi: 10.5114/wo.2023.133506. Epub 2023 Dec 6. Contemp Oncol (Pozn). 2023. PMID: 38239862 Free PMC article.

2

Richter's syndrome in the brain first manifested as an ischaemic stroke.

Robak T, Góra-Tybor J, Tybor K, Jamroziak K, Robak P, Kordek R, Rieske P, Majos A, Urbańska-Ryś H. Robak T, et al. Among authors: robak p. Leuk Lymphoma. 2004 Jun;45(6):1261-7. doi: 10.1080/10428190310001638823. Leuk Lymphoma. 2004. PMID: 15360010

3

Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.

Robak P, Linke A, Cebula B, Robak T, Smolewski P. Robak P, et al. Among authors: robak t. Leuk Lymphoma. 2006 Dec;47(12):2625-34. doi: 10.1080/10428190600948147. Leuk Lymphoma. 2006. PMID: 17169808

4

Current treatment options in prolymphocytic leukemia.

Robak T, Robak P. Robak T, et al. Among authors: robak p. Med Sci Monit. 2007 Apr;13(4):RA69-80. Med Sci Monit. 2007. PMID: 17392661 Review.

5

The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.

Robak P, Smolewski P, Robak T. Robak P, et al. Among authors: robak t. Leuk Lymphoma. 2008 Aug;49(8):1452-62. doi: 10.1080/10428190802108854. Leuk Lymphoma. 2008. PMID: 18608871 Review.

6

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

Robak T, Korycka A, Lech-Maranda E, Robak P. Robak T, et al. Among authors: robak p. Molecules. 2009 Mar 23;14(3):1183-226. doi: 10.3390/molecules14031183. Molecules. 2009. PMID: 19325518 Free PMC article. Review.

7

Current and emerging treatments for chronic lymphocytic leukaemia.

Robak T, Jamroziak K, Robak P. Robak T, et al. Among authors: robak p. Drugs. 2009;69(17):2415-49. doi: 10.2165/11319270-000000000-00000. Drugs. 2009. PMID: 19911856

8

TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies.

Robak T, Robak P, Smolewski P. Robak T, et al. Among authors: robak p. Curr Opin Investig Drugs. 2009 Dec;10(12):1383-90. Curr Opin Investig Drugs. 2009. PMID: 19943209 Review.

9

Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.

Robak T, Lech-Maranda E, Robak P. Robak T, et al. Among authors: robak p. Expert Rev Anticancer Ther. 2010 Oct;10(10):1529-43. doi: 10.1586/era.10.132. Expert Rev Anticancer Ther. 2010. PMID: 20942624 Review.

10

Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.

Robak T, Robak P. Robak T, et al. Among authors: robak p. Curr Pharm Des. 2012;18(23):3373-88. doi: 10.2174/138161212801227005. Curr Pharm Des. 2012. PMID: 22591387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters